Publication | Open Access
Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatment
10
Citations
23
References
2010
Year
The COBAS TaqMan HCV assay is very useful for monitoring HCV viremia during antiviral treatment to predict a SVR in HCV genotype 1 patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1